Name | Number of supported studies | Average coverage | |
---|---|---|---|
astrocyte | 18 studies | 59% ± 19% | |
oligodendrocyte precursor cell | 12 studies | 51% ± 17% | |
Mueller cell | 6 studies | 68% ± 16% | |
oligodendrocyte | 5 studies | 25% ± 5% | |
GABAergic neuron | 4 studies | 31% ± 8% | |
neuron | 4 studies | 24% ± 9% | |
endothelial cell | 3 studies | 21% ± 2% | |
retinal pigment epithelial cell | 3 studies | 33% ± 19% | |
glutamatergic neuron | 3 studies | 33% ± 5% | |
interneuron | 3 studies | 38% ± 4% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 25217.70 | 2640 / 2642 | 100% | 284.61 | 704 / 705 |
lymph node | 0% | 0 | 0 / 0 | 31% | 0.59 | 9 / 29 |
lung | 0% | 0 | 0 / 578 | 15% | 0.68 | 171 / 1155 |
uterus | 0% | 0 | 0 / 170 | 9% | 0.25 | 40 / 459 |
esophagus | 0% | 0 | 0 / 1445 | 8% | 0.24 | 14 / 183 |
stomach | 0% | 0 | 0 / 359 | 6% | 0.11 | 18 / 286 |
bladder | 0% | 0 | 0 / 21 | 6% | 0.19 | 31 / 504 |
eye | 0% | 0 | 0 / 0 | 5% | 0.34 | 4 / 80 |
liver | 0% | 0 | 0 / 226 | 5% | 0.12 | 20 / 406 |
breast | 0% | 0 | 0 / 459 | 5% | 0.12 | 53 / 1118 |
skin | 0% | 0 | 0 / 1809 | 4% | 0.10 | 17 / 472 |
tonsil | 0% | 0 | 0 / 0 | 2% | 0.04 | 1 / 45 |
intestine | 0% | 2.43 | 1 / 966 | 2% | 0.04 | 11 / 527 |
pancreas | 0% | 0 | 0 / 328 | 2% | 0.08 | 3 / 178 |
ovary | 0% | 0 | 0 / 180 | 1% | 0.02 | 5 / 430 |
adrenal gland | 0% | 10.63 | 1 / 258 | 0% | 0.00 | 1 / 230 |
prostate | 0% | 0 | 0 / 245 | 1% | 0.01 | 4 / 502 |
kidney | 0% | 0 | 0 / 89 | 1% | 0.02 | 5 / 901 |
thymus | 0% | 0 | 0 / 653 | 0% | 0.01 | 3 / 605 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
adipose | 0% | 0 | 0 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 0% | 0 | 0 / 1335 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
heart | 0% | 0 | 0 / 861 | 0% | 0 | 0 / 0 |
muscle | 0% | 0 | 0 / 803 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0005634 | Cellular component | nucleus |
GO_0003674 | Molecular function | molecular_function |
Gene name | MIR9-1HG |
Protein name | Protein CROC-4 (Contingent replication of cDNA 4) (MIR9-1 host gene) C1orf61 protein |
Synonyms | CROC4 C1orf61 |
Description | FUNCTION: May play a role in FOS signaling pathways involved in development and remodeling of neurons. Promotes transcription of the FOS promoter. . |
Accessions | Q86W69 Q13536 Q6PB34 |